Which class is used to influence the progression of rheumatoid arthritis?

Which class is used to influence the progression of rheumatoid arthritis?

• A. Antiviral
• B. Decongestant
• C. Disease-modifying antirheumatic drugs (DMARDs)
• D. Emetic

Answer: (C)

In rheumatoid arthritis, the goal is to slow or halt the damage to joints by acting on the underlying immune-driven inflammation. Disease-modifying antirheumatic drugs do exactly that: they dampen the abnormal immune response that drives synovial inflammation and cartilage destruction, aiming to reduce long-term joint damage and disability. They don’t just relieve symptoms; they change the course of the disease, which is why they’re central to RA management. They often take weeks to months to show meaningful effects, so early and sometimes combination use is common to protect joints over time. The other drug classes listed don’t influence the progression of RA. Antivirals treat viral infections, decongestants relieve nasal congestion, and emetics induce vomiting. None of these modify the autoimmune process or prevent structural joint damage in RA.

In rheumatoid arthritis, the goal is to slow or halt the damage to joints by acting on the underlying immune-driven inflammation. Disease-modifying antirheumatic drugs do exactly that: they dampen the abnormal immune response that drives synovial inflammation and cartilage destruction, aiming to reduce long-term joint damage and disability. They don’t just relieve symptoms; they change the course of the disease, which is why they’re central to RA management. They often take weeks to months to show meaningful effects, so early and sometimes combination use is common to protect joints over time.

The other drug classes listed don’t influence the progression of RA. Antivirals treat viral infections, decongestants relieve nasal congestion, and emetics induce vomiting. None of these modify the autoimmune process or prevent structural joint damage in RA.